Cargando…
Sensitivity of VHL mutant kidney cancers to HIF2 inhibitors does not require an intact p53 pathway
Inactivation of the VHL tumor suppressor gene is the signature initiating event in clear cell renal cell carcinoma (ccRCC), which is the most common form of kidney cancer. The VHL tumor suppressor protein marks hypoxia-inducible factor 1 (HIF1) and HIF2 for proteasomal degradation when oxygen is pre...
Autores principales: | Stransky, Laura A., Vigeant, Sean M., Huang, Bofu, West, Destiny, Denize, Thomas, Walton, Emily, Signoretti, Sabina, Kaelin, William G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168943/ https://www.ncbi.nlm.nih.gov/pubmed/35357972 http://dx.doi.org/10.1073/pnas.2120403119 |
Ejemplares similares
-
Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
por: Kondo, Keiichi, et al.
Publicado: (2003) -
Playing Tag with HIF: The VHL Story
por: Leung, Sherri K., et al.
Publicado: (2002) -
VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions
por: Mathó, Cecilia, et al.
Publicado: (2022) -
VHL and Hypoxia Signaling: Beyond HIF in Cancer
por: Zhang, Jing, et al.
Publicado: (2018) -
Renal Tubular HIF-2α Expression Requires VHL Inactivation and Causes Fibrosis and Cysts
por: Schietke, Ruth E., et al.
Publicado: (2012)